Please be informed that the SEC amended Exchange Act Rule 15c2-11, which governs the publication or submission of quotations by broker-dealers in a quotation medium other than a national securities exchange, has become effective. The SEC adopted amendments to enhance disclosure and investor protection in the US OTC market by ensuring that broker-dealers do not publish quotations for an issuer’s security when current issuer information is not publicly available. These changes may significantly restrict or in certain scenarios prohibit client’s ability to initiate transactions in the US OTC market or to exit client’s pre-existing position. In addition, this is likely to reduce the liquidity and pricing transparency of these product and client could be negatively impacted by acquiring or maintaining existing US OTC securities. Client should make the decision to invest in OTC market only after due and careful consideration.

Should you have any queries, please contact your Account Manager or call our Customer Service Hotline at (852) 3555 7878.